Please login to the form below

Not currently logged in
Email:
Password:

Vintura appoints Lieven Annemans as an associate partner

He will advise the consultancy's clients on market access issues

Lieven AnnemansHealthcare and life sciences consultancy firm Vintura has appointed health-economics professor Lieven Annemans as an associate partner after previously working with him in health-economic areas.

His new role will see him advise international life sciences organisations with market access challenges.

Bas Amesz, partner at Vintura, said: “Lieven adds valuable knowledge and international experience in the areas of health-economics and value-based healthcare.

“Furthermore, Lieven is also a valuable addition to our team, he is an inspiring ‘thought leader’ with a no-nonsense work ethic and a pleasure to work with.”

The professor teaches in the faculty of medicine and health sciences at Ghent University based in Belgium and he is also president of the Flemish Healthcare council.

“By joining forces with Lieven we will increase our ability to create meaningful impact in healthcare by advising and supporting healthcare organisations, industry and government.

“This way we will jointly contribute to the realisation of universal and equitable access of patients to new therapies.”

Annemans has served in a variety of roles including president of the Internation Society for Pharmaeconomics and Outcomes Research (ISPOR), former cabinet advisor to secetary Frank Vandenbroucke and is the laureate of the Francqui chair in 2013 and 2016.

10th July 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics